WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Bulevirtide

Governed registry record

4 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D.

    DOI: 10.1056/nejmoa2213429

    Source identity and connection checked by Codex (AI).

  2. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D.

    DOI: 10.1056/nejmoa2314134

    Source identity and connection checked by Codex (AI).

  3. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.

    DOI: 10.1016/j.jhep.2024.05.001

    Source identity and connection checked by Codex (AI).

  4. Bulevirtide: First Approval.

    DOI: 10.1007/s40265-020-01400-1

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Asselah T
  • Chulanov V
  • Lampertico P
  • Wedemeyer H
  • Streinu-Cercel A
  • Pântea V
  • Lazar S
  • Placinta G
  • Gherlan GS
  • Bogomolov P
  • Stepanova T
  • Morozov V
  • Syutkin V
  • Sagalova O
  • Manuilov D
  • Mercier RC
  • Ye L
  • Da BL
  • Chee G
  • Lau AH
  • Osinusi A
  • Bourliere M
  • Ratziu V
  • Pol S
  • Hilleret MN
  • Zoulim F
  • Aleman S
  • Brunetto MR
  • Blank A
  • Andreone P
  • Mamonova N
  • Geyvandova N
  • Berger A
  • Suri V
  • An Q
  • Da B
  • Flaherty J
  • Liu Y
  • Merle U
  • Schulze Zur Wiesch J
  • Zeuzem S
  • Ciesek S
  • Cornberg M
  • MYR 301 Study Group
  • Kang C
  • Syed YY
  • Brunetto M
  • Chee GM
  • Li M
  • Flaherty JF